The Complainants are "Dr. Martens" International Trading GmbH of Gräfelfing, Germany and “Dr. Maertens" Marketing GmbH of Seeshaupt, Germany, represented by Beetz & Partner, Germany.
The Respondent is Amrinal Pn of Bekasi, Jawa Barat, Indonesia.
The disputed domain name <docmartens.me> (the “Domain Name”) is registered with GoDaddy.com, LLC (the “Registrar”).
The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on March 13, 2012. On March 13, 2012, the Center transmitted by email to the Registrar a request for registrar verification in connection with the disputed domain name. On March 14, 2012, the Registrar transmitted by email to the Center its verification response confirming that the Respondent is listed as the registrant and providing the contact details. An amendment to the Complaint was received by the Center on March 20, 2012.
The Center verified that the Complaint together with the amendment to the Complaint satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy, approved by the doMEn d.o.o (“doMEn”) (the “Policy” or “UDRP”), the Rules for Uniform Domain Name Dispute Resolution Policy approved by the doMEn (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”).
In accordance with the Rules, paragraphs 2(a) and 4(a), the Center formally notified the Respondent of the Complaint, and the proceedings commenced on March 22, 2012. In accordance with the Rules, paragraph 5(a), the due date for Response was April 11, 2012. The Respondent did not submit any response. Accordingly, the Center notified the Respondent’s default on April 17, 2012.
The Center appointed Michelle Brownlee as the sole panelist in this matter on April 20, 2012. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7.
The Complainants own several registrations for the trademark DR. MARTENS, including:
- Community Trade Mark Registration No. 59147 for footwear and clothing in International Class 25 and retail services in Class 35
- Canadian Trademark Registration No. 420485 for footwear and clothing in class 25
- Canadian Trademark Registration No. 625884 for retail services for footwear and clothing in class 35
- United States Trademark Registration No. 1454323 for footwear in International Class 25
- United States Trademark Registration No. 1798791 for footwear in International Class 25
- United States Trademark Registration No. 2838397 for retail services for footwear and clothing in International Class 35
The Complainants also own United States Registration No. 2397734 for DOC MARTENS for footwear in International Class 25, and Community Trade Mark Registration No. 150144 for DOC MARTENS for footwear and clothing in International Class 25 and retail services in International Class 35.
The Domain Name was registered on November 12, 2011.
DR. MARTENS is a famous international trademark for footwear, clothing and accessories, particularly renowned for its distinctive shoes and boots, first sold in the late 1950’s. DR. MARTENS footwear, clothing and accessories are available for sale at retailers throughout the world as well as online at the Complainants’ website, located at the domain name <docmartens.com>.
The web site that is displayed at the Domain Name is not authorized by the Complainants, but has a prominent heading on the page that reads “DOC MARTENS BOOT UK – DR. MARTENS UK” and displays a copyright notice that reads “Copyright © 2011 Doc Martens Boot UK.” The site is offering DR. MARTENS footwear for sale.
The Complainants contend that the Domain Name is identical to their DOC MARTENS mark. The Complainants further submit that the Respondent does not have any rights to or legitimate interests in respect of the Domain Name and that the Respondent registered and is using the Domain Name in bad faith. The Complainants argue that by using the well-known DOC MARTENS mark, the Respondent is likely to mislead and deceive consumers into believing that the Respondent has a sponsorship, affiliation or approval with the Complainants when this is not the case.
The Respondent did not reply to the Complainants’ contentions.
Paragraph 4(a) of the Policy provides that in order to be entitled to a transfer of a domain name, a complainant must prove the following three elements:
(1) the domain name is identical or confusingly similar to a trademark or service mark in which the complainant has rights; and
(2) the respondent has no rights to or legitimate interests in respect of the domain name; and
(3) the domain name has been registered and is being used in bad faith.
The Complainants have demonstrated that they own rights in the DOC MARTENS trademark. The Panel finds that the Domain Name is identical to the DOC MARTENS mark.
Paragraph 4(c) of the Policy provides that a respondent can demonstrate rights to or legitimate interests in a domain name by demonstrating one of the following facts:
(i) before receiving any notice of the dispute, the respondent used or made demonstrable preparations to use the domain name at issue in connection with a bona fide offering of goods or services; or
(ii) the respondent has been commonly known by the domain name; or
(iii) the respondent is making a legitimate noncommercial or fair use of the domain name without intent for commercial gain, to misleadingly divert consumers or to tarnish the trademark at issue.
In this case, the Respondent has not presented evidence that the Respondent used or made demonstrable preparations to use the Domain Name in connection with a bona fide offering of goods or services; that the Respondent is commonly known by the Domain Name; that the Respondent is making a legitimate noncommercial or fair use of the Domain Name; or in any other way refuted the Complainants’ prima facie case.
The Complainants have presented evidence, which was not refuted by the Respondent, that the Respondent is using the Domain Name to pass itself off as related to the Complainants, by hosting a website which features listings for the sale of the Complainants’ and the Complainants’ competitors’ products. The Panel finds that this activity cannot under the circumstances be considered a bona fide offering of goods or services. Accordingly, the Panel finds that the Respondent does not have any rights to or legitimate interests in respect of the Domain Name.
Paragraph 4(b) of the Policy states that the following circumstances are evidence of registration and use of a domain name in bad faith:
“(i) circumstances indicating that the respondent has registered or acquired the domain name at issue primarily for the purpose of selling, renting, or otherwise transferring the domain name registration to the complainant who is the owner of the trademark or service mark or to a competitor of that complainant, for valuable consideration in excess of documented out-of-pocket costs directly related to the domain name; or
(ii) the respondent registered the domain name in order to prevent the owner of the trademark or service mark from reflecting the mark in a corresponding domain name, provided that the respondent has engaged in a pattern of such conduct; or
(iii) the respondent has registered the domain name primarily for the purpose of disrupting the business of a competitor; or
(iv) by using the domain name, the respondent has intentionally attempted to attract, for commercial gain, Internet users to its web site or other online location, by creating a likelihood of confusion with the complainant’s mark as to the source, sponsorship, affiliation, or endorsement of its web site or location or of a product or service on its web site or location.”
The Panel finds that the Complainants have established bad faith registration and use under paragraph 4(b)(iv) of the Policy. The content posted on the web site associated with the Domain Name demonstrates that the Respondent is aware of the Complainant’s DOC MARTENS trademark, as the site appears to be selling DR. MARTENS footwear. Further, the Panel finds that the Respondent is using the Domain Name to attract Internet users to the Respondent’s site by creating confusion as to source and results in commercial gain to the Respondent since the Respondent is offering products for sale on the site. The likelihood of confusion is exacerbated in this case by the prominent use of the Complainants’ DOC MARTENS and DR. MARTENS marks in the heading of the page and in the copyright notice.
For the foregoing reasons, in accordance with paragraphs 4(i) of the Policy and 15 of the Rules, the Panel orders that the Domain Name <docmartens.me> be transferred to the Complainants.
Michelle Brownlee
Sole Panelist
Dated: April 30, 2012